Naixin is working as a Scientist at Tectonic in Boston with the immuno & in vivo team.
Education
Ph.D., Physiology, University of Minnesota, Department of Integrative Biology and Physiology, 2022
Thesis: FFAR4 regulates cardiac oxylipin balance to promote the resolution of inflammation in HFpEF secondary to metabolic syndrome
Advisors: Timothy O'Connell, PhD / Catherine Kotz, PhD
M.S., Pharmacology and Drug Development,Tufts University, 2016
B.S., Biology and Biotechnology, Hunan University, Department of Integrative Biology and Physiology, 2014
Awards
- Dr. Marvin and Hadassah Bacaner Research Award in Physiology, 2023
- Dean’s Distinguished Graduate Fellowship, University of Minnesota, 2016
Publications
- Zhang, N., Murphy, K. A., Harsch, B., Zhang, M., Gyberg, D. J., Wagner, B. M., ... & O'Connell, T. (2022). Free fatty acid receptor 4 (FFAR4) regulates cardiac oxylipin balance to promote inflammation resolution in a model of heart failure preserved ejection fraction secondary to metabolic syndrome. bioRxiv. https://doi.org/10.1101/2022.04.13.488227 (Under revision)
- O’Connell, T. D., Murphy, K. A., Zhang, N., Puccini, S. J., Healy, C. L., Harsch, B. A., ... & Shearer, G. C. (2022). Signaling through free fatty acid receptor 4 attenuates cardiometabolic disease. Physiology, 37(6), 311-322.